Morgan Stanley Finance LLC has filed a new pricing supplement for market-linked notes due October 31, 2030. This filing, dated October 29, 2026, is significant as it showcases the company's strategy to expand its offerings in structured investments, particularly for investors looking for exposure to the S&P 500 index.
The notes, which are fully and unconditionally guaranteed by Morgan Stanley, will not pay interest but will offer returns based on the performance of the S&P 500 index. The stated principal amount for these notes is set at $1,000 per note, with an aggregate principal amount of $2,027,000.
Background
Morgan Stanley Finance LLC, classified under the SIC code 6211 for Security Brokers, Dealers & Flotation Companies, is a subsidiary of Morgan Stanley. The company is incorporated in Delaware and has its business address at 1585 Broadway, New York, NY. Recent filings include multiple pricing supplements, all dated October 29, 2026, highlighting the company's active engagement in the market.
What the Filing Says
The filing includes details about the notes, stating, "The notes are unsecured obligations of Morgan Stanley Finance LLC and are fully and unconditionally guaranteed by Morgan Stanley." It also outlines the payment structure at maturity, which depends on the final level of the S&P 500 index compared to its initial level.
Impact
This filing may affect a range of stakeholders, including potential investors who are looking for structured products that offer a combination of principal protection and market-linked returns. The notes are designed for those who are concerned about principal risk but are willing to forgo current income for potential future gains.
What's Next
The filing does not say what happens next, but it indicates that Morgan Stanley Finance LLC is actively pursuing opportunities in the structured investment market.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










